Tag: FluidX medical

embolic device

Metastatic tumour treatment with novel GPX embolic device

An embolic device by Fluidx Medical has been used successfully in a variety of complex cancer cases, according to a company press release. As part...
GPX-Clear Image Set FluidX Medical

Fluidx Medical’s embolic device demonstrates promising visibility 

Fluidx Medical Technology has announced the results of the GPX-Clear embolic device in-vivo research which uses the base GPX technology and incorporates an intermediate-term...
GPX syringe

Fluidx Medical reports successful use of GPX embolic device in challenging...

Fluidx Medical recently announced that its GPX embolic device was used to effectively devascularise a large tumour with multiple feeding vessels as part of...
Fluidx Medical’s GPX embolic device

Fluidx Medical Technology announces Series A led by multinational strategic investor

Fluidx Medical Technology, has recently announced the oversubscribed closing of the first tranche of the Series A financing round. The Series A was led...
Fluidx Medical’s GPX embolic device

Innovative embolic device shows promise for interventional oncology drug delivery

Fluidx Medical’s GPX embolic device has released initial results for Oncology Drug Delivery. Fluidx Medical Technology announced that a next-generation, doxorubicin-loaded GPX embolic device...
GPX

New embolic device blocks vessels feeding malignant tumours

Fluidx Medical have released details on the clinical use of their GPX embolic device, demonstrating its ability to block flow to small microvasculature and...

New proprietary gel-coated biocompatible embolic, GPX, presented at LINC

Two scientific abstracts of a new vascular embolic device, GPX (Fluidx Medical Technology) were presented this week at the 2018 Leipzig Interventional Congress (LINC;...